ライフサイエンスコーパス: eligibility

1 o 75 years (+/-10 years age-related Medicare eligibility).

2 th 29% power if Braak stage had not used for eligibility.

3 cs and detoxification units and assessed for eligibility.

4 both eyes, and 535 underwent assessment for eligibility.

5 atient's risk for heart failure to determine eligibility.

6 diovascular health (P<0.001) during Medicare eligibility.

7 xplained by differences in potential patient eligibility.

8 and assessed an interaction with time since eligibility.

9 ized as relevant clinical variables for HSCT eligibility.

10 to the study, of whom 369 were assessed for eligibility.

11 nd a concomitant increase in exclusions from eligibility.

12 Exposures: Dual Medicare and Medicaid eligibility.

13 celona Clinic Liver Cancer (BCLC) stages for eligibility.

14 ent scales might help the decision making on eligibility.

15 gists' beliefs and decisions about recipient eligibility.

16 scatheter mitral valve implantation size and eligibility.

17 eless electrical activity) were assessed for eligibility.

18 July 14, 2014, we screened 725 patients for eligibility.

19 ry total knee arthroplasty were screened for eligibility.

20 nd June, 2016, 376 infants were assessed for eligibility.

21 heir measurements recorded at the margins of eligibility.

22 m North America and Europe were assessed for eligibility.

23 nd Feb 24, 2014, we assessed 1308 people for eligibility.

24 Jan 15, 2015, 858 patients were screened for eligibility.

25 ry health-care clinics and were screened for eligibility.

26 June 8, 2016, 2960 schools were assessed for eligibility; 2029 were eligible, and a random sample of

27 e AD or nonatopic subjects were assessed for eligibility, 347 of whom received intradermal or intramu

28 58, were prescreened; 518 were assessed for eligibility; 433 were randomized; and 187 were eligible

29 l, 6838 patients were screened for dementia (eligibility: 70 years and older and living at home) from

30 d Feb 11, 2015, of 173 patients assessed for eligibility, 74 patients were randomly assigned to recei

31 Among 656 studies screened for eligibility, 7604 individuals were included from 8 prosp

32 Seventeen reports and 1896 patients met eligibility; 8 (47%) studies were retrospective, 5 (29%)

33 Among 131 individuals screened for eligibility, 99 patients met DSM-IV criteria for ADHD, a

34 ry prevention cohort, guideline-based statin eligibility accurately identified patients at a higher r

35 ve been understudied, because of restrictive eligibility across all phases of clinical trials.

36 Eighteen studies met eligibility across six countries: Australia, United Stat

37 arch, of which 71 articles were assessed for eligibility after exclusion of 919 records.

38 Eligibility also required either left atrial enlargement

39 ays on which patients were excluded from SBT eligibility among all mechanically ventilated patients.

40 xploited the quasi-random assignment of DACA eligibility among mothers with birthdates close to the D

41 The 16 eQMs with >/=70% specificity in eligibility and >/=70% sensitivity in pass rates include

42 Feb 4, 2016, 166 patients were assessed for eligibility and 124 patients were enrolled and randomly

43 Dec 4, 2015, 163 patients were assessed for eligibility and 126 patients were randomly assigned to l

44 Oct 3, 2012; 757 patients were assessed for eligibility and 301 were randomly assigned to receive ei

45 2, 2015, 113 participants were screened for eligibility and 98 were randomly assigned from 20 out of

46 tudies with sufficient information regarding eligibility and adequate quality scores were considered

47 , 2014, three participants were assessed for eligibility and enrolled at RUMC, and were assigned to r

48 wo reviewers independently evaluated article eligibility and extracted data on study designs, populat

49 Two reviewers evaluated studies for eligibility and extracted hazard ratios for ischemic str

50 Fourteen articles met eligibility and inclusion criteria for systematic review

51 al trials applied consistent definitions for eligibility and outcomes.

52 ON: Two authors independently assessed study eligibility and performed data extraction.

53 wide readmission measure to broaden hospital eligibility and provide incentives for improvement acros

54 The trial management system confirmed eligibility and randomly allocated participants in block

55 eviewers independently assessed articles for eligibility and the authors of eligible trials were appr

56 surrogate endpoints for determining patient eligibility and treatment efficacy.

57 Jan 27, 2014, 452 patients were assessed for eligibility, and 380 patients were randomly assigned.

58 ls/L, universal antiretroviral therapy [ART] eligibility, and 5-year retention rate of 84%) and scale

59 Articles were screened for eligibility, and any possible discrepancies in this scre

60 ed for demographic characteristics, Medicaid eligibility, and area-level covariates.

61 ated differences in subject characteristics, eligibility, and changes in regulations governing reside

62 me, mean time to linkage, assessment for ART eligibility, ART initiation and time to ART initiation,

63 re assigned to immediate versus deferred ART eligibility, as determined by a CD4 count < 350 cells/mu

64 This tool may be used for patient eligibility assessment or risk stratification in future

65 March 17, 2016, we screened 186 patients for eligibility at 48 hospitals across 20 countries.

66 32 participants with NPC1 were assessed for eligibility at the National Institutes of Health.

67 purpose of this study was to evaluate statin eligibility based on the 2013 American College of Cardio

68 307 patients were assessed for eligibility between Dec 21, 2009, and Oct 31, 2012.

69 leeve gastrectomy (LSG) increases transplant eligibility by reducing BMI in kidney transplant candida

70 Expansion of ART eligibility CD4 counts of 350-500 cells per muL is cost-

71 ntion group had started ART by 2 weeks after eligibility compared with 2585 of 7066 patients (38%) in

72 outcomes among individuals who met key DACA eligibility criteria (based on age at immigration and at

73 mination than standard lung cancer screening eligibility criteria (c-statistic = 0.66 [0.64 to 0.69])

74 od and Drug Administration examined specific eligibility criteria (ie, brain metastases, minimum age,

75 29 studies that met the eligibility criteria (ie, economic evaluations, cluster-

76 Patients who met the eligibility criteria (male sex, age <6 years, severe hem

77 ts who post-hoc objectively did not meet the eligibility criteria (modified intention-to-treat).

78 ution.Thirteen observational studies met the eligibility criteria (n < 1700 cases).

79 terature search was conducted using specific eligibility criteria across electronic databases, includ

80 Using only four BC eligibility criteria and all patients with OC, an estima

81 Specific eligibility criteria and baseline evaluations depend on

82 Results A total of 104 studies met eligibility criteria and compose the evidentiary basis f

83 A total of 63 studies met eligibility criteria and compose the evidentiary basis f

84 haracteristics of U.S. adults meeting SPRINT eligibility criteria and determine the broader populatio

85 atic reviews and 63 primary studies, met the eligibility criteria and form the evidentiary basis for

86 010 to December 2016, 793 patients met Z0011 eligibility criteria and had SLN metastases.

87 (Systolic Blood Pressure Intervention Trial) eligibility criteria and may benefit from a SBP target g

88 lationships established may help outline the eligibility criteria and outcome measures for clinical t

89 d all randomly assigned participants who met eligibility criteria and received any dose of a trial dr

90 4 unique abstracts screened, 53 articles met eligibility criteria and reported on 44 studies; 31 stud

91 elve studies comprising 274 patients met the eligibility criteria and were included for analysis.

92 405 articles identified, 21 met the initial eligibility criteria and were included in the analysis.

93 7 patients (95 males and 72 females) met the eligibility criteria and were included in the study.

94 including 1,455 participants, fulfilled the eligibility criteria and were included in the systematic

95 SD-OCT data, 45 eyes of 24 patients met the eligibility criteria and were included in this subanalys

96 t (five enrolled patients later did not meet eligibility criteria and were not dosed with study drug)

97 2312 of these patients met all eligibility criteria and were randomly assigned to treat

98 Secondary eligibility criteria are described later.

99 Clinical trial eligibility criteria are necessary to define the patient

100 Purpose The primary purposes of eligibility criteria are to protect the safety of trial

101 Eligibility criteria assessment was conducted by 2 of us

102 After screening, and applying eligibility criteria based on relevance to the research

103 The broadening of clinical trial eligibility criteria can be considered to better reflect

104 Excessive or overly restrictive eligibility criteria can slow trial accrual, jeopardize

105 s in trial design and conduct to examine how eligibility criteria could be more inclusive.

106 gs for randomized controlled trials that met eligibility criteria defined for each question.

107 Of 1026 potential participants who fulfilled eligibility criteria during telephone screening, 701 (68

108 A total of 3857 participants (53.0%) met eligibility criteria for at least 1 RCT.

109 However, there are concerns that eligibility criteria for cancer clinical trials are too

110 The first addresses reporting of eligibility criteria for centers where the intervention

111 we have conducted a comprehensive review of eligibility criteria for commercial investigational new

112 Our findings suggest that eligibility criteria for current cancer clinical trials

113 Of 5068 studies found, 127 met eligibility criteria for data extraction.

114 in published studies included the following: eligibility criteria for donors (47%), materials used fo

115 Of 3025 trauma patients assessed, 1030 met eligibility criteria for enrollment, and 446 declined pa

116 en Jan 1, 2000, and Jan 9, 2015, and met the eligibility criteria for inclusion in our study.

117 A total of 56 studies met eligibility criteria for inclusion in the review includi

118 Eligibility criteria for inclusion of couple-years of fo

119 rong predictive ability, which could improve eligibility criteria for lung cancer screening programs.

120 been initiatives to re-examine and modernize eligibility criteria for oncology clinical trials.

121 er than 36 hours were randomized if they met eligibility criteria for partial ventilatory support, to

122 Key eligibility criteria for participants included BRAF V600

123 Patients and Methods Eligibility criteria for patients from our database were

124 Eligibility criteria for patients with asthma were broad

125 Participants met the following eligibility criteria for ready-made spectacles: failed v

126 y of the risk prediction model for selecting eligibility criteria for screening.

127 bstantial percentage of U.S. adults meet the eligibility criteria for SPRINT.

128 rt Association (ACC/AHA) guidelines expanded eligibility criteria for statins.

129 Of the 25420 patients who met the eligibility criteria for study inclusion, the mean (SD)

130 y of DAA trials was assessed by applying the eligibility criteria from 5 efficacy trials: NCT01479868

131 om 2011 to 2015; and a review of HIV-related eligibility criteria from National Cancer Institute-spon

132 Models for HIV-related eligibility criteria in National Cancer Institute-sponso

133 Eligibility criteria included a distance control score o

134 Eligibility criteria included a recently diagnosed adeno

135 Patient eligibility criteria included age 18 years or older, Eas

136 Eligibility criteria included age 2 to 17 years, AD diag

137 Eligibility criteria included all studies reporting on t

138 Eligibility criteria included any published English-lang

139 Eligibility criteria included assessment of macronutrien

140 Additional eligibility criteria included disease duration of 2-10 y

141 Key eligibility criteria included measurable disease, failur

142 Eligibility criteria included patients who received a di

143 Patients and Materials Study eligibility criteria included patients with stage II to

144 Eligibility criteria included previous normal vision for

145 Eligibility criteria included WHO performance status 0 o

146 t 2017 National Comprehensive Cancer Network eligibility criteria on the basis of age of diagnosis an

147 The models outperformed the NLST eligibility criteria over a substantial range of risk th

148 Testing rates for individual eligibility criteria ranged from 6.2% (relative with OC)

149 Eligibility criteria related to HIV infection that addre

150 Critical review of eligibility criteria related to HIV is required to accel

151 of SRs did not report use of a SR protocol, eligibility criteria relating to publication status, yea

152 Working Group developed recommendations for eligibility criteria that focus on pharmacologic and imm

153 s of unclear clinical significance or narrow eligibility criteria that limit external validity, and i

154 nsensus on recommendations regarding updated eligibility criteria that prioritize inclusiveness witho

155 abetic Retinopathy Clinical Research Network eligibility criteria thresholds of CST for trials evalua

156 Cardiology/American Heart Association statin eligibility criteria to identify individuals at a higher

157 We discuss potential areas for expanding eligibility criteria to include more patients in clinica

158 Median time (Q1, Q3) from meeting full eligibility criteria to RRT initiation was significantly

159 Key eligibility criteria were an Eastern Cooperative Oncolog

160 Key eligibility criteria were an ECOG performance status of

161 SPRINT eligibility criteria were applied to the 1999 to 2006 Na

162 Abstracts meeting eligibility criteria were collected by a research librar

163 The primary eligibility criteria were current nicotine dependence (D

164 Eligibility criteria were fever higher than 38 degrees C

165 Eligibility criteria were met in 181 websites.

166 Eligibility criteria were self-identification as transwo

167 least one dose of PCV13; cases had the same eligibility criteria with the addition of having WHO-def

168 In contrast, the NLST eligibility criteria yielded a sensitivity of 71.4% and

169 nursing home elderly (aged >/=65 y) who met eligibility criteria, 58% had a low serum zinc concentra

170 We identified 6127 studies, of which 18 met eligibility criteria, all from middle- or high-income co

171 al and clinical heterogeneity in tests used, eligibility criteria, and proteinuria prevalence (8.7%-9

172 dently screened articles for congruence with eligibility criteria, engaged in data extraction, and as

173 ed 60-75 y, consistent with Generation Study eligibility criteria, from the National Alzheimer's Coor

174 iews related to refractive error; 39 met our eligibility criteria, of which we classified 11 to be re

175 Of 39,884 patients meeting our eligibility criteria, the median time on ART to 31 Decem

176 comprising 1511 patients (all children) met eligibility criteria.

177 440 [39%] women), 1074 (94%) of patients met eligibility criteria.

178 LCO were compared to those based on the NLST eligibility criteria.

179 We identified 71 publications that met eligibility criteria.

180 alent, in order to hold fixed two other DACA eligibility criteria.

181 s for clinical trials incorporating expanded eligibility criteria.

182 Of 2812 articles screened, 11 met the eligibility criteria.

183 dren (n = 454; age range, 3 mo to 18 yr) met eligibility criteria.

184 Of 1553 studies identified, 91 met the full eligibility criteria.

185 Twenty-four studies met eligibility criteria.

186 Of the 371 articles identified, ten met eligibility criteria.

187 investigating 10 opioid drugs fulfilled the eligibility criteria.

188 Canadian hospitals in 2014 using consistent eligibility criteria.

189 7 observational and 3 randomized trials) met eligibility criteria.

190 lts with treated hypertension met the SPRINT eligibility criteria.

191 oaden participation through changes in their eligibility criteria.

192 Data Synthesis: Eighty-three studies met eligibility criteria.

193 we found 373 abstracts, 91 of which met our eligibility criteria.

194 and overweight or obese participants met the eligibility criteria.

195 ied as potentially eligible and 18 fulfilled eligibility criteria.

196 identified by literature search, 16 met the eligibility criteria.

197 sis and 1138 in the K6 analysis met the DACA eligibility criteria.

198 ochrane guidance.Twenty-four studies met the eligibility criteria: 1 randomized controlled trial, 4 n

199 ur review, a study had to meet the following eligibility criteria: be published in a peer-reviewed jo

200 lish or Spanish, and presented to the ED met eligibility criteria; 136 of 298 eligible patients were

201 The group analyzed current eligibility criteria; conducted original data analysis;

202 Results In all, 125 patients met eligibility criteria; median follow-up was 51 months for

203 For BC, 35.6% met one or more select eligibility criteria; of those, 29.0% discussed, 20.2% w

204 than patients who just missed the CD4-count eligibility cutoff.

205 ar of birth and sex on the immigrant's first eligibility date.

206 3%]) among the 1082 NIS studies screened for eligibility did not account for the effects of sampling

207 n in their third trimester were screened for eligibility either during community outreach or at home-

208 goal was achieved), lottery incentive (daily eligibility [expected value approximately $1.40] if goal

209 Two authors working independently assessed eligibility, extracted data, and evaluated the risk of b

210 Continuous eligibility for 6 months or more before the first NIIPPU

211 lish in these subjects clinical criteria for eligibility for an ASA challenge and/or desensitization.

212 cores HER2, a biomarker that defines patient eligibility for anti-HER2 targeted therapies in breast c

213 linkage to care) and three clinical stages (eligibility for antiretroviral therapy [ART], initiation

214 ART initiation 14 days after first clinical eligibility for ART.

215 f degree of nonreversible kidney injury; (3) eligibility for combined (either simultaneous or staged)

216 llowing the ESC guideline, and we determined eligibility for each of 10 major RCTs for primary preven

217 y ill patients by assessing the incidence of eligibility for each trial.

218 Five studies assessed the morphological eligibility for EVAR (1507 men, 400 women).

219 income for people with psychoses and confer eligibility for health insurance.

220 Feb 26, 2014, 368 patients were assessed for eligibility for inclusion in the trial.

221 atients with psoriasis to aid in determining eligibility for methotrexate sodium (MTX) therapy, monit

222 e: The Affordable Care Act expanded Medicaid eligibility for millions of low-income adults.

223 as calculated from birth to death (or end of eligibility for outcome, at age 1 year) and pregnancy (g

224 Eligibility for primary prevention statin therapy.

225 To determine the difference in eligibility for primary prevention statin treatment amon

226 Prompting consideration of eligibility for specialist consultation by electronic he

227 Change in eligibility for statins was assessed based on the third

228 Eligibility for stepping down asthma controller medicati

229 anada Permanent Resident Database with first eligibility for the Ontario Health Insurance Plan betwee

230 Eligibility for treatment was judged in accordance with

231 es identified in our search and screened for eligibility, four trials of cardiovascular outcomes of G

232 open-label trial, patients were screened for eligibility from 52 clinical centres in Canada, France,

233 e expansions in antiretroviral therapy (ART) eligibility from an initial CD4+ threshold of </=200 cel

234 e classified children into immunoprophylaxis eligibility groups and calculated adherence (percentage

235 heast Mali) and Bamako (capital of Mali) for eligibility (>/=2000 asexual P falciparum parasites per

236 rtance: Patients with dual Medicare-Medicaid eligibility have a higher burden of chronic disease cond

237 up-classified from optional to clear statin eligibility if CAC was >/=100 (or equivalent cPB).

238 nal counselling on the result, including ART eligibility if CD4 was less than 350 cells per muL, the

239 uding transcatheter aortic valve replacement eligibility in low-risk patients across 37 advanced econ

240 rial and calculated rates of potential trial eligibility in the cohort.

241 Eligibility included a minimum requirement of FRalpha po

242 Eligibility included adults with a hematological maligna

243 SPRINT eligibility included age >/=50 years, SBP of 130 to 180

244 Eligibility included endocrine-refractory, estrogen rece

245 Key eligibility included washout IOP of 23 mmHg or more at t

246 Statin eligibility increased among all race, education, and inc

247 Expanded Medicaid eligibility is associated with shorter hospital LOS in m

248 d potentially relevant and were assessed for eligibility, leading to the inclusion of 27 studies in t

249 The 2013 ACC/AHA guidelines increase statin eligibility most among adults with nonwhite race, socioe

250 mized controlled trial and then assessed the eligibility of each patient admitted to a study ICU for

251 nine reviewers working in pairs assessed the eligibility of the identified studies based on titles an

252 il 29, 2011, 1837 patients were screened for eligibility, of whom 1277 patients were randomly assigne

253 15, 2016, 742 participants were screened for eligibility, of whom 657 were randomly assigned to treat

254 d-June, 2015, 628 patients were screened for eligibility, of whom 79 were randomly assigned to treatm

255 18, 2016, 165 participants were assessed for eligibility, of whom 84 did not meet the inclusion crite

256 ne 30, 2014, 1096 patients were assessed for eligibility, of whom 929 were randomly assigned (464 to

257 0 August 2015, 1,393 women were screened for eligibility on the basis of psychological distress and i

258 d medication use were compared and change in eligibility over time was reported at 6 months and 1 yea

259 430 (29%) would have met criteria for statin eligibility per the 2013 American College of Cardiology/

260 ts, older adults with dual Medicare-Medicaid eligibility presenting with MI have superior rates of me

261 Study eligibility required that after 4 weeks of optimized tre

262 To assess current eligibility requirements for cancer clinical trials, we

263 ncluding 239 diet arms and 4,220 adults, met eligibility requirements.

264 CI 1.18-1.86, p = 0.002), assessment for ART eligibility (RR 1.20, 95% CI 1.07-1.34, p = 0.004), ART

265 cognitively normal older adults who provided eligibility screening data for the University of Kansas'

266 Mothers' DACA eligibility significantly decreased adjustment and anxie

267 About eligibility, specificity varied from 25% (brain imaging;

268 Methods Eligibility stipulated disease progression within 6 mont

269 hout any changes in the standards for gifted eligibility, the screening program led to large increase

270 We assessed villages for eligibility then randomly selected 150 for the study usi

271 four patients (25%) presenting close to the eligibility threshold (95% CI 20% to 31%; p < 0.001).

272 if urine was not tested, or if the extended eligibility time for molecular testing was not implement

273 on tomography scans and its use to determine eligibility to a trial, could dramatically improve the p

274 Conclusion Expanding eligibility to be more inclusive of patients with brain

275 Conclusion Expanding clinical trial eligibility to be more inclusive of patients with HIV is

276 Eligibility to immunotherapy is based on the determinati

277 Purpose Broadening trial eligibility to improve accrual and access and to better

278 e scientifically appropriate to expand trial eligibility to include children younger than age 18 year

279 Restriction based on Medicare-payment eligibility to patients with length of stay >/=3days (SN

280 P pairing, thus revealing a timing-dependent eligibility trace on which reinforcement operates.

281 System database, and chart review confirmed eligibility, treatment assignment, and outcomes.

282 data (2009-2014) were used to assess statin eligibility under the 2016 USPSTF recommendations vs the

283 ne the association between expanded Medicaid eligibility under the Affordable Care Act and duration o

284 The expansion of Medicaid eligibility under the Affordable Care Act is a state-lev

285 We compared statin eligibilities using 2 separate approaches: a 10-year ris

286 ge, region, gender, time period, and vaccine eligibility using multivariable Poisson regression with

287 ght to personalize ACC/AHA risk-based statin eligibility using noninvasive assessment of subclinical

288 Efforts to refine statin eligibility via coronary calcification have been studied

289 lity of individuals with ADHD 6 months after eligibility was 35% lower (for males: adjusted hazard ra

290 Thirdly, inclusion eligibility was assessed by title, abstract, and full te

291 Medicare eligibility was associated with an abrupt 6.4 (95% confi

292 Statin eligibility was determined per American College of Cardi

293 Subsequently, eligibility was expanded to pregnant women with sexual p

294 among men, blacks, and people with Medicaid eligibility was higher than that in the rest of the popu

295 Eligibility was independently assessed by 2 of us.

296 To evaluate eQMs in terms of eligibility, we calculated the proportion of patients wh

297 stimates of disease prevalence and treatment eligibility were calculated using stochastic simulation

298 Race and socioeconomic differences in statin eligibility were more pronounced under the 2013 ACC/AHA

299 e association of programmatic changes in ART eligibility with loss from care, both prior to ART initi

300 risk thresholds at which applying risk-based eligibility would improve lung cancer screening efficacy